Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 27;14(9):1073.
doi: 10.3390/life14091073.

The Patient's Journey in Obesity within the United States: An Exercise of Resilience against Disease

Affiliations
Review

The Patient's Journey in Obesity within the United States: An Exercise of Resilience against Disease

Kayla Northam et al. Life (Basel). .

Abstract

Obesity is often viewed as a result of patient failure to adhere to healthy dietary intake and physical activity; however, this belief undermines the complexity of obesity as a disease. Rates of obesity have doubled for adults and quadrupled for adolescents since the 1990s. Without effective interventions to help combat this disease, patients with obesity are at increased risk for developing type 2 diabetes, heart attack, stroke, liver disease, obstructive sleep apnea, and more. Patients often go through several barriers before they are offered pharmacotherapy or bariatric surgery, even though evidence supports the use of these interventions earlier. This partially stems from the cultural barriers associated with using these therapies, but it is also related to healthcare provider bias and limited knowledge of these therapies. Finally, even when patients are offered treatment for obesity, they often run into insurance barriers that keep them from treatment. There needs to be a cultural shift to accept obesity as a disease and improve access to effective treatments sooner to help decrease the risk of health complications associated with obesity.

Keywords: bariatric surgery; barriers to care; obesity; pharmacotherapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Illustrating the different factors contributing to a patient’s journey to treat obesity.

References

    1. Obesity and Overweight. [(accessed on 31 March 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight#....
    1. Narayan A., Agarwal A.A., Stanford C.F. Challenges with Relying on Body Fat and Weight Values for Obesity—Reply. JAMA Intern. Med. 2024;184:990–991. doi: 10.1001/jamainternmed.2024.2376. - DOI - PMC - PubMed
    1. Overweight and Obesity. [(accessed on 1 June 2024)]; Available online: https://www.cdc.gov/obesity/php/about/index.html.
    1. Waldrop W.S., Johnson R.V., Stanford C.F. Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity. Nat. Med. 2024;30:22–25. doi: 10.1038/s41591-023-02669-x. - DOI - PMC - PubMed
    1. Kyle K.T., Nadglowski F.J., Stanford C.F. Weight Management and Healthy Lifestyles. JAMA Intern. Med. 2020;180:1403. doi: 10.1001/jamainternmed.2020.2743. - DOI - PMC - PubMed

LinkOut - more resources